# Christopher A. Bristow

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-a-bristow/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,760 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 47 |
| i10-index | 68 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5012999075 |
| ORCID iD | https://orcid.org/0009-0009-9266-6849 |
| Works | 252 |

## Researcher papers

- [Genomic Classification of Cutaneous Melanoma](https://scholariq.org/papers/genomic-classification-of-cutaneous-melanoma/)
- [The Molecular Taxonomy of Primary Prostate Cancer](https://scholariq.org/papers/the-molecular-taxonomy-of-primary-prostate-cancer/)
- [Integrated Genomic Characterization of Papillary Thyroid Carcinoma](https://scholariq.org/papers/integrated-genomic-characterization-of-papillary-thyroid-carcinoma/)
- [Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma](https://scholariq.org/papers/molecular-profiling-reveals-biologically-discrete-subsets-and-pathways-of/)
- [Identification of Functional Elements and Regulatory Circuits by <i>Drosophila</i> modENCODE](https://scholariq.org/papers/identification-of-functional-elements-and-regulatory-circuits-by-i-drosophila-i/)
- [An inhibitor of oxidative phosphorylation exploits cancer vulnerability](https://scholariq.org/papers/an-inhibitor-of-oxidative-phosphorylation-exploits-cancer-vulnerability/)
- [The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma](https://scholariq.org/papers/the-somatic-genomic-landscape-of-chromophobe-renal-cell-carcinoma/)
- [A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations](https://scholariq.org/papers/a-pan-cancer-proteogenomic-atlas-of-pi3k-akt-mtor-pathway-alterations/)
- [Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy](https://scholariq.org/papers/increased-tumor-glycolysis-characterizes-immune-resistance-to-adoptive-t-cell/)
- [Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state](https://scholariq.org/papers/resistance-to-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-mediated/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Biochemical and Molecular Research](https://scholariq.org/topics/biochemical-and-molecular-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.